Quad Capital Management Advisors’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-130,000
Closed -$23.4M 161
2017
Q3
$23.4M Buy
+130,000
New +$18.1M 4.8% 8

Quad Capital Management Advisors's KITE Position: Q4 2017 in Review

Quad Capital Management Advisors sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 192,537 shares — an estimated $34.6M sold.

Quad Capital Management Advisors first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $34.6M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Quad Capital Management Advisors reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Quad Capital Management Advisors sold 192,537 Kite Pharma, Inc. shares in Q4 2017, an estimated $34.6M.
  • Quad Capital Management Advisors first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
  • Quad Capital Management Advisors's Kite Pharma, Inc. position peaked at $34.6M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Quad Capital Management Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.